James, E., Robertshaw, T. L., & Westwell, A. D. | Future Medicinal Chemistry | 14 February 2019
Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019
Ona, G., & Troncoso, S. | Journal of Psychedelic Studies |12 February 2019
The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis
Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., & Bouso, J. C. | Journal of psychoactive drugs | 7 February 2019
Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019
Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. | Journal of Psychopharmacology | 5 February 2019
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., ... & Tagliazucchi, E. | Consciousness and cognition | 1 February 2019
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., ... & Erritzoe, D. | Neuropsychopharmacology | 26 January 2019
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019